A non-interventional extension study for patients treated in study R5459-RT-1944 with REGN5459 or REGEN5458 (BCMAxCD3 bispecific antibodies [bsAbs]) that receive a kidney transplant

Project: Research project

Project Details

Description

A non-interventional extension study for patients treated in study R5459-RT-1944 with REGN5459 or REGEN5458 (BCMAxCD3 bispecific antibodies [bsAbs]) that receive a kidney transplant
StatusActive
Effective start/end date2/1/2412/31/26

Funding

  • REGENERON PHARMACEUTICALS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.